Trexquant Investment LP Protagonist Therapeutics, Inc Transaction History

Trexquant Investment LP

  • $8.06 Billion
  • Q4 2024

A detailed history of Trexquant Investment LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Trexquant Investment LP holds 92,788 shares of PTGX stock, worth $3.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
92,788
Previous 23,091 301.84%
Holding current value
$3.59 Million
Previous $1.04 Million 245.32%
% of portfolio
0.04%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$38.51 - $48.43 $2.68 Million - $3.38 Million
69,697 Added 301.84%
92,788 $3.58 Million
Q3 2024

Nov 12, 2024
SELL
$33.72 - $47.33 $1.94 Million - $2.72 Million
-57,523 Reduced 71.36%
23,091 $1.04 Million
Q2 2024

Aug 13, 2024
SELL
$24.66 - $34.8 $536,724 - $757,421
-21,765 Reduced 21.26%
80,614 $2.79 Million
Q1 2024

May 14, 2024
BUY
$21.79 - $32.15 $2.23 Million - $3.29 Million
102,379 New
102,379 $2.96 Million
Q2 2023

Aug 11, 2023
BUY
$18.02 - $29.36 $205,662 - $335,085
11,413 New
11,413 $315,000
Q3 2022

Nov 14, 2022
BUY
$7.86 - $11.71 $176,229 - $262,549
22,421 New
22,421 $189,000
Q2 2022

Aug 11, 2022
SELL
$7.06 - $25.52 $69,152 - $249,968
-9,795 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$23.34 - $36.08 $228,615 - $353,403
9,795 New
9,795 $232,000
Q2 2021

Aug 12, 2021
SELL
$25.57 - $44.88 $269,047 - $472,227
-10,522 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$19.02 - $31.15 $143,639 - $235,244
-7,552 Reduced 41.78%
10,522 $273,000
Q4 2020

Feb 11, 2021
BUY
$18.49 - $25.13 $334,188 - $454,199
18,074 New
18,074 $364,000
Q3 2020

Nov 06, 2020
SELL
$15.19 - $22.4 $162,639 - $239,836
-10,707 Closed
0 $0
Q2 2020

Aug 07, 2020
SELL
$6.19 - $18.84 $60,501 - $184,142
-9,774 Reduced 47.72%
10,707 $189,000
Q1 2020

May 08, 2020
BUY
$5.4 - $9.22 $110,597 - $188,834
20,481 New
20,481 $145,000
Q1 2019

May 13, 2019
SELL
$6.5 - $13.77 $119,060 - $252,225
-18,317 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$6.3 - $10.44 $70,956 - $117,585
-11,263 Reduced 38.08%
18,317 $123,000
Q3 2018

Nov 09, 2018
BUY
$6.82 - $11.26 $201,735 - $333,070
29,580 New
29,580 $304,000
Q2 2018

Aug 07, 2018
SELL
$5.99 - $9.1 $134,810 - $204,804
-22,506 Closed
0 $0
Q1 2018

May 03, 2018
BUY
$8.46 - $23.08 $45,684 - $124,631
5,400 Added 31.57%
22,506 $193,000
Q4 2017

Feb 09, 2018
BUY
$14.47 - $20.8 $247,523 - $355,804
17,106
17,106 $356,000

Others Institutions Holding PTGX

# of Institutions
253
Shares Held
58.9M
Call Options Held
226K
Put Options Held
218K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.9B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email